Helice

Hélice represents an innovative financial engineering initiative built upon the Blockchain (Polygon) platform with the primary goal of reducing the cost of bionic prosthetics and artificial organs by 50%. These encompass a wide spectrum of advanced medical technologies, including retinal implants, prosthetic arms, neuroprosthetics, artificial hearts, exoskeletons, among others. We find ourselves disheartened by the exorbitant pricing, approximately $100,000, associated with these technologies, and the sluggish pace of development within these fields. The highly customized nature of these devices poses significant challenges to mass production, which consequently inflates prices. Moreover, the biotechnology sector faces substantial hurdles in advancing innovation, often requiring up to a decade to generate revenue, leading to diminished investments in this critical domain. Herein lies the significance of Hélice's financial engineering endeavor. Firstly, by disrupting the prevailing cycle through the halving of prices, and secondly, by generating an infusion of capital to expedite the development of these technologies within our forthcoming research laboratory.